PubMed HealthSearch

Biomedical subjects

L Valladares

Publications and source records attributed to L Valladares.

2 recordsLinked to original sources

Hormonal control of gene expression: differential activation of rat bone marrow RNA polymerases by erythropoietin and testosterone.

Hormones play a role in the regulation of gene expression by inducing changes in enzyme patterns in target cells mediated by the synthesis of specific RNA molecules. Erythropoiesis has been used as a system for studying the molecular mechanism of regulation of gene action by means of two hormones: erythropoietin and testosterone. Experiments designed to correlate the biochemical action of both hormones on rat marrow cells are herein reported. Both factors seems to act at different biochemical and citological levels. Erythropoietin triggers the erythropoietic process acting on the erythropoietin sensitive cells (ESC), in which the hormone induces the synthesis of a high molecular weight RNA, which is the precursor of a functional 9 S messenger RNA. Testosterone seems to act on polychromatophilic erythroblasts, in which the synthesis of ribosomal RNA or its precursor is stimulated. The steroid enhances the nuclear ribonuclease activity, which could represent a control mechanism for the processing (maturation) of high molecular weight RNAs. The incorporation of 3H-GTP and 3H-UTP into RNA by isolated rat bone marrow nuclei is stimulated by erythropoietin and testosterone. Using alpha-amanitine and different ionic strength conditions it was found that erythropoietin enhances preferentially RNA polymerase II activity while testosterone increases RNA polymerase I activity. It is postulated that erythropoietin and testosterone act synergically to create the biochemical machinery for hemoglobin synthesis, the macromolecule that characterizes the erythropoietic process.

Amanitins

Characterization of a nuclear receptor for testosterone in rat bone marrow.

In vitro testosterone binding was studied in a nuclear extract (0.15 M KC1) from rat bone marrow using the charcoal assay. The nuclear extract contains binding sites saturable at low concentration of testosterone (1 times 10-8M). From a Scatchard plot of the data obtained it is concluded that a single class of receptor sites is involved in the binding of testosterone. Studies indicated that the testosterone-nuclear complex has a dissociation constant (Kd) of 5.9 times 10-9 M binding 9 times 10-14 moles/mg nuclear protein. 5alpha- and 5beta-dihydrotestosterone compete poorly with testosterone for binding sites in the nuclear component while estradiol -17beta does not compete at all. The protein nature of the receptor was demonstrated and an isoelectric point (pI) of 4.9 was determined for the complex by the use of isoelectric focusing.

Animals